Medexus Pharmaceuticals Inc (TSE:MDP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Medexus Pharmaceuticals has successfully concluded negotiations with the pan-Canadian Pharmaceutical Alliance to make Trecondyv, a treosulfan injection, accessible through public drug programs in Canada. This milestone reflects the high demand for Trecondyv in the country and strengthens its market potential. The decision now awaits final approval for public reimbursement by government organizations.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.
